Parkman Healthcare Partners’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Parkman Healthcare Partners’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-890,099	Closed	-$2.25M	–	117
2023 Q4	$2.25M	Buy	+890,099	New	+$2.07M	0.32%	72

Parkman Healthcare Partners's SLGC Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 890,099 shares — an estimated $2.25M sold.

Parkman Healthcare Partners first reported a position in SLGC in Q4 2023 and held it in 1 quarter. The position peaked at $2.25M in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Parkman Healthcare Partners reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Parkman Healthcare Partners sold 890,099 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $2.25M.
Parkman Healthcare Partners first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2023 and held it in 1 quarter.
Parkman Healthcare Partners's SomaLogic, Inc. Class A Common Stock position peaked at $2.25M in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.